OrbiMed Asia Partners VI, L.P.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filing history at a glance
The reported offering amount was $850,000,000 in the May 28, 2026 filing and $1,045,599,648 in the Oct 16, 2026 filing. The two records may concern different offerings. Amendments account for 2 of the 3 filings stored from Sep 29, 2025 to Oct 16, 2026.
through Oct 16, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | May 28, 2026 · D/A | Oct 16, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $850,000,000 | $1,045,599,648 | $195,599,648 |
| Reported amount sold | $533,984,000 | $1,045,599,648 | $511,615,648 |
| Reported investor count | 45 | 72 | 27 |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0002087034-26-000002 · Later SEC source: 0002087034-26-000003
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $1,045,599,648
- Reported exemptions
- Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(7)
- Reported amount sold
- $1,045,599,648
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20262 filings
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Likely investment adviser (not guaranteed)
Best-effort name match against Form ADV. Click through for AUM, employees, and disciplinary disclosures.
-
ORBIMED CAPITAL LLC
medium CRD 801-61952
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- OrbiMed Genesis Fund, L.P. · CIK 1796304
- OrbiMed Genesis Fund, Ltd. · CIK 1808344
- OrbiMed Partners II, L.P. · CIK 1324240
- OrbiMed Partners, Ltd. · CIK 1459984
- OrbiMed Private Investments X, LP · CIK 2087033
Form D filings (3)
-
0002087034-26-000003D/A · Oct 16, 2026 · Pooled Investment FundOffering: $1,045,599,648Sold: $1,045,599,648
Compared with 0002087034-26-000002:
- Reported offering amount: $850,000,000 → $1,045,599,648
- Reported amount sold: $533,984,000 → $1,045,599,648
- Reported investor count: 45 → 72
-
0002087034-26-000002D/A · May 28, 2026 · Pooled Investment FundOffering: $850,000,000Sold: $533,984,000
Compared with 0002087034-25-000001:
- Reported amount sold: $0 → $533,984,000
- Reported investor count: Unavailable → 45
-
0002087034-25-000001D · Sep 29, 2025 · Pooled Investment FundOffering: $850,000,000Sold: $0